ArticleBMC infectious diseases2026
Prevalence and pattern of transfusion transmitted infections among blood donors visiting a tertiary care hospital, Pakistan.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Seroprevalence and Risk Factors for Transfusion-transmitted Infections among Blood Donors in Dera Ismail Khan, Pakistan: A Single-Center Cross-sectional Study.Journal of epidemiology and global health · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to assess the prevalence and patterns of HIV, HBV, HCV, and syphilis among blood donors in Pakistan.
methodsData records of all registered blood donors (n = 63,847) during August 2020-April 2025, at a blood transfusion center in a tertiary care hospital were retrospectively analyzed. Prevalence of the seropositive donors for HIV, HCV, HBV and Syphilis was analyzed.
resultsThe donors ranged in age from 18 years to over 65 years, with the vast majority being male (99.47%). Overall prevalence of TTIs was 2.04% in the donor population. Hepatitis B virus (HBV) was the most prevalent TTI (1.12%; 95% CI: 1.04–1.20), followed by hepatitis C virus (HCV) (0.49%; 95% CI: 0.44–0.55), syphilis (0.36%; 95% CI: 0.32–0.41), and human immunodeficiency virus (HIV) (0.07%; 95% CI: 0.05–0.09) respectively. Replacement donations accounted for 59.34% of the total. The largest proportion of donors (48.7%) were aged 26–35 years. The highest annual donation volume occurred in 2023, with 13,534 donors. The most frequent coinfections were HBV–HCV and HBV–syphilis, with seven cases each.
conclusionAmong blood donors, HBV was the most prevalent transfusion-transmitted infection, followed by HCV. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.